Recombinant Anti-Ang2 x Anti-VEGFA Bispecific Antibody (scFv-Fc) (BSCFV-008)

Recombinant Anti-Ang2 x Anti-VEGFA Bispecific Antibody (scFv-Fc) is formed by fusing two different scFv fragments to the hinge and Fc regions, in which the Fc region are engineered by KIH. Two of scFv moiety has the antibody variable domain of either anti-Ang2 specificity or anti-VEGFA specificity, which produces bivalent IgG-like molecules with desired characteristics of intact antibodies. This BsAb is capable of inhibiting two proangiogenics fators and a combined blockade of them has a greater inhibitory efficacy compared with inhibition of either factor alone. It is designed for the research of Colorectal cancer (CRC); Solid tumors; Wet AMD (Age-related macular degeneration); Diabetic macular edema therapy.

Datasheet INQUIRY

Specifications

Targets

Ang2 & VEGFA

Type

scFv-based Bispecific Fragments

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Colorectal cancer (CRC); Solid tumors; Wet AMD (Age-related macular degeneration); Diabetic macular edema

Targets

Target 1

Ang2

Gene ID

285

UniProt ID

O15123

Alternative Names

ANGPT2; Ang2; angiopoietin 2; ANG2; AGPT2; angiopoietin-2; ANG-2; Tie2-ligand; angiopoietin-2B; angiopoietin-2a

Target 2

VEGFA

Gene ID

7422

UniProt ID

P15692

Alternative Names

VEGFA; vascular endothelial growth factor A; VPF; VEGF; MVCD1; vascular permeability factor

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-Ang2 x Anti-VEGFA Bispecific Antibody (scFv-Fc) (BSCFV-008). Click the button below to contact us or submit your feedback about this product.

Recombinant Anti-Ang2 x Anti-VEGFA Bispecific Antibody (scFv-Fc) (CAT#: BSCFV-008)

Specifications

Targets

Customer Reviews and Q&As